首页 | 本学科首页   官方微博 | 高级检索  
     

急性冠脉综合征患者氯吡格雷抵抗与近期疗效的临床观察
引用本文:陈碧莲,解勤之,李清. 急性冠脉综合征患者氯吡格雷抵抗与近期疗效的临床观察[J]. 中国临床药理学与治疗学, 2009, 14(3): 328-332
作者姓名:陈碧莲  解勤之  李清
作者单位:1. 中南大学湘雅医院干部医疗科,长沙,410008,湖南
2. 中南大学湘雅医院血液科,长沙,410008,湖南
3. 中南大学临床药理研究所,长沙,410008,湖南
摘    要:目的:检测急性冠脉综合征(acute coronary syndrome,ACS)患者服用氯吡格雷治疗前后腺苷二磷酸(adenosine diphosphate,ADP)诱导的血小板聚集率变化,同时观察临床主要心血管事件发生率。方法:测定88名冠心病稳定型心绞痛患者和102名ACS患者服用氯吡格雷前与服用后第5天ADP诱导的血小板聚集率,按照血小板聚集率的抑制程度分为无反应、低反应和正常反应组。同时观察单纯药物治疗和联合支架置入术治疗患者1月内主要心血管事件发生率。结果:服用氯吡格雷前,ACS患者ADP诱导的血小板聚集率明显高于稳定型心绞痛患者[(80.4±7.8)%US(56.2±12.1)%,P〈0.05]。ACS患者服用氯吡格雷的过程中,无反应患者、低反应患者的发生率分别是21.6%、27.4%。结论:ACS患者呈现出血小板高聚集状态。服用氯吡格雷后血小板聚集率的抑制程度呈现明显个体差异。氯吡格雷无反应和低反应患者在治疗过程中,心绞痛发生率明显高于氯吡格雷正常反应患者(P〈0.05)。联合支架置入术患者心绞痛发生率低于单纯药物治疗患者(P〈0.05)。

关 键 词:急性冠脉综合征  氯吡格雷  血小板聚集率

Clinical observation of clopidogrel resistance and clinical outcomes on patients with acute coronary syndrome
CHEN Bi-lian,XIE Qin-zhi,LI Qing. Clinical observation of clopidogrel resistance and clinical outcomes on patients with acute coronary syndrome[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(3): 328-332
Authors:CHEN Bi-lian  XIE Qin-zhi  LI Qing
Affiliation:1Department of Geriatrics, 2Department of Hematology, Xiangya Hospital, 3Institute of Clinical Pharmacology, Central South University, Changsha 410008, Hunan, China)
Abstract:AIM: To detect ADP ( adenosine diphosphate)-induced platelet aggregation rate of patients with acute coronary syndrome before and after clopidogrel treatment and survey the main cardiovascular events. METHODS: ADP-induced platelet aggregation rates of 88 cases stable angina pectoris patients and 102 cases acute coronary syndrome (ACS) patients were detected before and after 5 days clopidogrel treatment. Patients were divided into three groups: nonresponders, low responders and normal re-sponders according to inhibition degree. The main cardiovascular events were recorded during a month among using simple drug treatment and ACS patients. RESULTS: ADP-induced platelet aggregation rate with ACS patients was much higher than that of patients with stable angina pectoris [ (80.4 ± 7.8) % vs (56.2 ±12.1)%, P < 0.05 ] before clopidogrel treatment. Incidence rates of nonresponders and low responders were 21.6% and 27.4% respectively during using clopidogrel treatment. CONCLUSION: Patients with ACS have a higher platelet aggregation state. Inhibition levels of platelet aggregation rate have significant inter-individual difference after clopidogrel treatment. Incidence rates of diaphragmatic angina in nonresponders and low responders were obviously higher than that in normal responders( P < 0.05) . Incidence rate of angina pectoris using drug-eluting stent implantation was lower than that using simple drug treatment ( P < 0.05).
Keywords:acute coronary syndrome  clopidogrel  platelet aggregation ratio
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号